70261-82-4,With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.70261-82-4,4-(4-Methylpiperazin-1-ylmethyl)phenylamine,as a common compound, the synthetic route is as follows.
EXAMPLE 119: 1 -(4-methoxybenzyl)-3-methyl-N-(4-((4-methylpiperazin- 1 – yl)methyl)phenyl)-lH-pyrazolor3,4-b1pyridin-5-amineA stirred solution of 5-bromo-l-(4-methoxybenzyl)-3-methyl-lH-pyrazolo[3,4-b]pyridine (7) (50 mg, 0.150 mmol) and 4-((4-methylpiperazin-l-yl)methyl)aniline (165) (30 mg, 0.165 mmol, 1.1 eq) in 1,4-dioxane (10 mL) was degassed and purged with N2 for 10 min. tert- uOK (50 mg, 0.451 mmol, 3.0 eq) was added and the reaction mixture was purged and degassed again. To this reaction mixture was added +/-BINAP (1.8 mg, 0.00301 mmol, 0.01 eq) and Pd2(dba)3 (5 mg, 0.0012 mmol, 0.04 eq) and the resulting reaction was heated at 90C for 12 hrs in sealed tube condition. After completion of the reaction the contents were cooled and diluted with CHC13 and filtered through Celite bed. The CHC13 layer was completely distilled off to get the crude product. The crude was passed through 100-200 mesh silica gel, eluting the pure compound 1- (4-methoxybenzyl)-3 -methyl-N-(4-((4-methylpiperazin- 1 -yl)methyl)phenyl)- lH-pyrazolo [3 ,4- b]pyridin-5 -amine 166 obtained with 6% MeOH in CH2C12 as an off-white coloured solid in 30 mg quantity.
The synthetic route of 70261-82-4 has been constantly updated, and we look forward to future research findings.
Reference：
Patent; ARRIEN PHARMAEUTICALS LLC; VANKAYALAPATI, Hariprasad; APPALANENI, Rajendra, P.; REDDY, Y., Venkata Krishna; WO2012/135631; (2012); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics